Treating chronic atrial fibrillation and associated atrial contraction dysfunction, using calcium ion sensitizers, preferably 3,6-dihydro-1,3,4-thiadiazin-2-one derivatives

摘要

Use of calcium ion sensitizers (I) (including their derivatives, solvates, stereoisomers and mixtures of stereoisomers in all ratios) in the production of a medicament for (i) treating chronic atrial fibrillation (AF), (ii) treating atrial contraction dysfunction induced by chronic AF and/or (iii) increasing the atrial-myocardial contractile force in chronic AF patients.